Live Breaking News & Updates on Aemophilia C

Stay updated with breaking news from Aemophilia c. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Trial Halted for Bleeding Reduction With Abelacimab in AF

The phase 2 AZALEA-TIMI 71 trial in AF shows "an overwhelming reduction" in major and clinically relevant nonmajor bleeding with investigational Factor XI inhibitor abelacimab vs rivaroxaban. ....

United States , Dan Bloomfield , Marc Sabatine , National Blood Clot Alliance , Drug Administration , Anthos Therapeutics , Thenew England Journal , North America , Latin America , Middle East , Leslie Lake , Atrial Fibrillation , F Atrial Fibrillation , Anticoagulation Therapy , Erebrovascular Accident , Va Cerebrovascular Accident , Venous Thromboembolism , Factor Xi Deficiency , Aemophilia C , Lasma Thromboplastin Antecedent Pta Deficiency , Rosenthal Syndrome , Aemophilia C ,